Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111745 · ClinicalTrials.gov registry record
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 730
- Enrollment target
NCT03111745: Completed study, sponsored by National Cancer Institute (NCI).
NCT03111745 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 730 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111745 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 730 participants
- Enrollment target
Study Summary
Background: Some blood and immune disorders can be helped with HSCT. This is allogeneic hematopoietic stem cell transplantation. The person who gets the stem cells has their immune system suppressed. This is done to help prevent their body from rejecting the transplant. During this time, the person is at a high risk to get viral infections. Researchers want to study the records of people who had transplants a few years ago. They want to look at how often certain viral complications happened. Objective: To study how often certain viral complications occurred after HSCT and what risks factors were involved. Eligibility: Records will be reviewed. No participants will be contacted. Design: Researchers will review medical records from the NIH Clinical Center. The records will be from people who had HSCT between 2010 and 2015 when they were between 4 and 85 years old. They already gave consent for their data to be studied. Data collected will include: Vital statistics like age and sex Viral status of the recipient and donor Reason for transplant Transplant details How the immune system recovered after transplant If the recipient got graft versus host disease Any infections Overall survival
Primary Outcome
Incidence and risk factors for various viral complications by HSCT platform and its relation to immune reconstitution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 730 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2020-02-18 |
What the finished NCT03111745 record still lists
NCT03111745 is an observational study that tracks outcomes without assigning an intervention. The registered 730 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03111745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03111745 about?
NCT03111745 is a clinical study titled "Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010". Background: Some blood and immune disorders can be helped with HSCT. This is allogeneic hematopoietic stem cell transplantation. The person who gets the stem cells has their immune system suppressed. This is done to help prevent their body from rejecting the transplant. During this time, the person...
What is the current status of trial NCT03111745?
This trial is currently completed. The enrollment target is 730 participants. The study started on 2017-04-13. Estimated completion is 2020-02-18.
Who is sponsoring clinical trial NCT03111745?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- NCT07312162 · 730 participants
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI